Suyang Hao

Suyang Hao, MD

Associate Professor of Clinical Pathology and Genomic Medicine, Academic Institute
Houston Methodist
Weill Cornell Medical College


Publications

Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with MYC rearrangement
Khanlari, M, Tang, G, Hao, S, Gong, Y, Li, S, Miranda, RN, Lin, P, Iyer, S, Yin, CC, Xie, W, Vega, F, Medeiros, LJ & Xu, J 2021, , British Journal of Haematology, vol. 192, no. 1, pp. e17-e21. https://doi.org/10.1111/bjh.17169

Peripheral T cell lymphoma, NOS with aberrant aß and ?d T cell receptor expression in a post-heart transplant patient
Liu, S, Ewton, A, Miller, TN, Zieske, AW, Thrall, MJ, Olsen, RJ, Zu, Y & Hao, S 2020, , Journal of Hematopathology, vol. 13, no. 2, pp. 109-116. https://doi.org/10.1007/s12308-020-00393-w

The survival impact of CKS1B gains or amplification is dependent on the background karyotype and TP53 deletion status in patients with myeloma
Hao, S, Lu, X, Gong, Z, Bassett, RL, Hu, S, Konoplev, SN, Tang, G, Li, S, Xu, J, Khanlari, M, Lee, HC, Manasanch, EE, Weber, DM, Orlowski, RZ, Jeffrey Medeiros, L & Lin, P 2021, , Modern Pathology, vol. 34, no. 2, pp. 327-335. https://doi.org/10.1038/s41379-020-00669-7

“Double-expressor” intravascular large B-cell lymphoma involving the female genital tract
Alrabeh, R & Hao, S 2018, , Blood, vol. 131, no. 26, pp. 2993. https://doi.org/10.1182/blood-2018-03-839001

Clinical implications of cytogenetic heterogeneity in multiple myeloma patients with TP53 deletion
Hao, S, Lin, P, Medeiros, LJ, Fang, L, Carballo-Zarate, AA, Konoplev, SN, Sargent, RL, Weber, DM, Thomas, SK, Manasanch, EE, Orlowski, RZ & Lu, X 2017, , Modern Pathology, vol. 30, no. 10, pp. 1378-1386. https://doi.org/10.1038/modpathol.2017.63

Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing
Wen, J, Tao, W, Hao, S & Zu, Y 2017, , Journal of Hematology and Oncology, vol. 10, no. 1, 119. https://doi.org/10.1186/s13045-017-0489-9

Additional-structural-chromosomal aberrations are associated with inferior clinical outcome in patients with hyperdiploid multiple myeloma: A single-institution experience
Carballo-Zarate, AA, Medeiros, LJ, Fang, L, Shah, JJ, Weber, DM, Thomas, SK, Manasanch, EE, Hao, S, Shen, Q, Orlowski, RZ, Lin, P & Lu, X 2017, , Modern Pathology, vol. 30, no. 6, pp. 843-853. https://doi.org/10.1038/modpathol.2017.3

Overt leukemic phase: an unusual presentation of angioimmunoblastic lymphoma
Arora, K, Zhang, L, Xie, W, Baker, KR, Zu, Y & Hao, S 2016, , Journal of Hematopathology, vol. 9, no. 3, pp. 139-142. https://doi.org/10.1007/s12308-016-0278-3

Whole-arm translocation of der(5;17)(p10;q10) with concurrent TP53 mutations in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): A unique molecular-cytogenetic subgroup
Hong, M, Hao, S, Patel, KP, Kantarjian, HM, Garcia-Manero, G, Yin, CC, Medeiros, LJ, Lin, P & Lu, X 2016, , Cancer Genetics, vol. 209, no. 5, pp. 205-214. https://doi.org/10.1016/j.cancergen.2016.04.001

A unique aptamer-drug conjugate for targeted therapy of multiple myeloma
Wen, J, Tao, W, Hao, S, Iyer, SP & Zu, Y 2016, , Leukemia, vol. 30, no. 4, pp. 987-91. https://doi.org/10.1038/leu.2015.216

Expression of CD25 independently predicts early treatment failure of acute myeloid leukaemia (AML)
Cerny, J, Yu, H, Ramanathan, M, Raffel, GD, Walsh, WV, Fortier, N, Shanahan, L, ORourke, E, Bednarik, J, Barton, B, Kroll-Desrosiers, A, Hao, S, Woda, B, Hutchinson, L, M. Evens, A, Rosmarin, AG & Nath, R 2013, , British Journal of Haematology, vol. 160, no. 2, pp. 262-266. https://doi.org/10.1111/bjh.12109

Conditional activation of ß-catenin signaling in mice leads to severe defects in intervertebral disc tissue
Wang, M, Tang, D, Shu, B, Wang, B, Jin, H, Hao, S, Dresser, KA, Shen, J, Im, HJ, Sampson, ER, Rubery, PT, Zuscik, MJ, Schwarz, EM, OKeefe, RJ, Wang, Y & Chen, D 2012, , Arthritis and Rheumatism, vol. 64, no. 8, pp. 2611-2623. https://doi.org/10.1002/art.34469

Smurf2 regulates the senescence response and suppresses tumorigenesis in mice
Ramkumar, C, Kong, Y, Cui, H, Hao, S, Jones, SN, Gerstein, RM & Zhang, H 2012, , Cancer research, vol. 72, no. 11, pp. 2714-2719. https://doi.org/10.1158/0008-5472.CAN-11-3773

The oncofetal protein IMP3: A novel molecular marker to predict aggressive meningioma
Hao, S, Smith, TW, Chu, PG, Liu. Q, Ok, CY, Woda, BA, Lu, D, Lin, P, Wang, SA, Dresser, K, Rock, KL & Jiang, Z 2011, , Archives of Pathology and Laboratory Medicine, vol. 135, no. 8, pp. 1032-1036. https://doi.org/10.5858/2009-0652-OAR2

IMP2 expression distinguishes endometrioid from serous endometrial adenocarcinomas
Zhang, L, Liu, Y, Hao, S, Woda, BA & Lu, D 2011, , American Journal of Surgical Pathology, vol. 35, no. 6, pp. 868-872. https://doi.org/10.1097/PAS.0b013e318219c6f9

High-level CD34 expression on megakaryocytes independently predicts an adverse outcome in patients with myelodysplastic syndromes
Tang, G, Wang, SA, Menon, M, Dresser, K, Woda, BA & Hao, S 2011, , Leukemia Research, vol. 35, no. 6, pp. 766-770. https://doi.org/10.1016/j.leukres.2011.01.009

Chronic basophilic leukemia: a rare form of chronic myeloproliferative neoplasm
Tang, G, Woods, LJ, Wang, SA, Brettler, D, Andersen, M, Miron, PM, Pechet, L, Woda, BA & Hao, S 2009, , Human Pathology, vol. 40, no. 8, pp. 1194-1199. https://doi.org/10.1016/j.humpath.2009.02.011

Activation of ß-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult ß-catenin conditional activation mice
Zhu, M, Tang, D, Wu, Q, Hao, S, Chen, M, Xie, C, Rosier, RN, OKeefe, RJ, Zuscik, M & Chen, D 2009, , Journal of Bone and Mineral Research, vol. 24, no. 1, pp. 12-21. https://doi.org/10.1359/jbmr.080901

Erythroid-predominant myelodysplastic syndromes: Enumeration of blasts from nonerythroid rather than total marrow cells provides superior risk stratification
Wang, SA, Tang, G, Fadare, O, Hao, S, Raza, A, Woda, BA & Hasserjian, RP 2008, , Modern Pathology, vol. 21, no. 11, pp. 1394-1402. https://doi.org/10.1038/modpathol.2008.142

Hypocellularity in myelodysplastic syndrome is an independent factor which predicts a favorable outcome
Yue, G, Hao, S, Fadare, O, Baker, S, Pozdnyakova, O, Galili, N, Woda, BA, Raza, A & Wang, SA 2008, , Leukemia Research, vol. 32, no. 4, pp. 553-558. https://doi.org/10.1016/j.leukres.2007.08.006

VIEW FULL PUBLICATIONS